If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Research Agreement with Arysta LifeScience

27 Apr 2012 11:49

RNS Number : 2414C
Plant Health Care PLC
27 April 2012
 

27 April 2012

 

Plant Health Care plc

 

PLANT HEALTH CARE TO CONDUCT RESEARCH ON

HARPIN PROTEIN WITH ARYSTA LIFESCIENCE

 

 

Plant Health Care, a leading provider of naturally-derived products to the global agriculture markets, announces that it has signed a research agreement with Arysta LifeScience to evaluate Harpin commercially as a foliar spray in combination with a number of Arysta LifeScience's products.

 

 

Harpin is a leading PHC product and has been shown to increase yields significantly on a variety of crops when applied alone or in combination with other active ingredients. Arysta LifeScience will test Harpin formulations in combination with a number of its actives. Harpin technology offers yield improvement as a result of suppression of pests, such as nematodes, and defense against damaging diseases, as well as additive plant health benefits. Under this agreement, improvements in yield, plant health and product efficacy will be evaluated in a range of crops and environmental situations.

 

 

John Brady, CEO of Plant Health Care, commented: "We are excited to establish a testing programme with Arysta LifeScience, an innovative global player in the crop protection industry with annual sales of $1.6 billion. Arysta LifeScience has been highly successful in incorporating new technologies into its extensive product portfolio and, with its global reach, a successful outcome will be a major benefit to PHC. We are optimistic that Arysta LifeScience's testing efforts will lead to eventual commercial development of an innovative high return product for growers worldwide."

 

 

Bill Lewis, head of global business initiatives, Arysta LifeScience, said: "Harpin technology has the potential to bring additional value to Arysta LifeScience's existing line of products and we are excited about the opportunity to evaluate the Harpin technology."

 

 

- ENDS -

 

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally-derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 40 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

 

 

For further information, please contact:

 

 

 

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

sweaver@planthealthcare.com

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Claire Terlouw / Chris Golden

www.nomuracode.com

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden

paul.durman@powerscourt-group.com

nick.dibden@powerscourt-group.com

 

 

 

 

 

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest privately held crop protection and life science company with 2011 revenues of JPY125.8 billion (US$1.6 billion). An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specialises in marketing and distribution of respected crop protection brands and life science products in harmony with the needs of global partners. More information on the company is available at: www.arystalifescience.com.

 

Contact:

Linda Frerichs Global Communications Manager

Arysta LifeScience Corporation

919-678-4948

linda.frerichs@arystalifescience.com

 

Tara Hart Public Relations Manager

Woodruff Sweitzer

816-255-1960

thart@woodruffsweitzer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAELXAFPAEFF
Date   Source Headline
1st Mar 201010:00 amRNSTotal Voting Rights
19th Feb 201010:30 amRNSDirector/PDMR Shareholding
16th Feb 201010:36 amRNSAdditional Listing and Directors' Shareholdings
16th Feb 20109:51 amRNSDual Listing on Channel Islands Stock Exchange
15th Feb 201012:26 pmRNSBlocklisting
15th Feb 20107:00 amRNSFinal Results
10th Feb 20107:00 amRNSSupply Agreement
4th Feb 20107:00 amRNSOrder for Myconate
2nd Feb 20107:00 amRNSTrial Results
1st Feb 201010:22 amRNSTotal Voting Rights
27th Jan 20107:00 amRNSTrading Statement
22nd Jan 20105:41 pmRNSAdditional Listing
12th Jan 20104:03 pmRNSDirector Declaration
31st Dec 20091:05 pmRNSTotal Voting Rights
29th Dec 20094:26 pmRNSAdditional Listing
8th Dec 20095:42 pmRNSAdditional Listing
1st Dec 200911:08 amRNSTotal Voting Rights
27th Nov 20092:55 pmRNSDirector/PDMR Shareholding
13th Nov 200911:52 amRNSHolding(s) in Company
10th Nov 20095:29 pmRNSAdditional Listing
6th Nov 200912:53 pmRNSAdditional Listing
4th Nov 20091:52 pmRNSAdditional Listing
2nd Nov 20091:29 pmRNSTotal Voting Rights
1st Oct 20094:21 pmRNSTotal Voting Rights
30th Sep 20095:31 pmRNSDirector/PDMR Shareholding
28th Sep 20096:21 pmRNSAdditional Listing
21st Sep 20099:47 amRNSPosting of Interim Results
21st Sep 20099:41 amRNSAdditional Listing
17th Sep 20096:01 pmRNSAdditional Listing
17th Sep 20095:06 pmRNSAdditional Listing
14th Sep 20097:05 amRNSSustainability Commendation
14th Sep 20097:00 amRNSInterim Results
9th Sep 20097:30 amRNSNotice of Results
1st Sep 200910:19 amRNSTotal Voting Rights
20th Aug 20092:58 pmRNSAdditional Listing
17th Aug 20097:00 amRNSExpansion of Partnership with Scotts
13th Aug 200912:55 pmRNSAdditional Listing
3rd Aug 200910:17 amRNSTotal Voting Rights
28th Jul 20093:05 pmRNSReplacement: Holding(s) in Company
28th Jul 200911:24 amRNSHolding(s) in Company
17th Jul 20091:39 pmRNSAdditional Listing
14th Jul 200912:59 pmRNSDirector/PDMR Shareholding
1st Jul 20097:01 amRNSRe: Monsanto announcement
1st Jul 20097:00 amRNSTotal Voting Rights
25th Jun 20097:00 amRNSSustainable Business 20
9th Jun 20098:35 amRNSDirector/PDMR Shareholding
5th Jun 200910:46 amRNSResult of AGM
4th Jun 20097:00 amRNSTechnical Presentation
3rd Jun 20099:17 amRNSSignificant Shareholding
2nd Jun 20097:00 amRNSMonsanto Order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.